AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families


You May Also Like

Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today ...

Trillium Therapeutics Reports Annual 2017 Financial and Operating Results

Presented evidence of clinical activity and good tolerability from both TTI-621 trials at ASHReceived ...